JP2006514098A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006514098A5 JP2006514098A5 JP2005501406A JP2005501406A JP2006514098A5 JP 2006514098 A5 JP2006514098 A5 JP 2006514098A5 JP 2005501406 A JP2005501406 A JP 2005501406A JP 2005501406 A JP2005501406 A JP 2005501406A JP 2006514098 A5 JP2006514098 A5 JP 2006514098A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- androgen receptor
- receptor modulator
- structural formula
- following chemical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 68
- 229940083324 Selective androgen receptor modulator Drugs 0.000 claims 33
- 239000000849 selective androgen receptor modulator Substances 0.000 claims 33
- 239000000126 substance Substances 0.000 claims 30
- 239000003814 drug Substances 0.000 claims 28
- 239000002207 metabolite Substances 0.000 claims 24
- 150000003839 salts Chemical class 0.000 claims 24
- 239000013078 crystal Substances 0.000 claims 23
- 229940002612 prodrug Drugs 0.000 claims 23
- 239000000651 prodrug Substances 0.000 claims 23
- 150000001204 N-oxides Chemical class 0.000 claims 19
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 18
- 150000004677 hydrates Chemical class 0.000 claims 15
- 125000000217 alkyl group Chemical group 0.000 claims 12
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 10
- 206010060862 Prostate cancer Diseases 0.000 claims 10
- 125000003342 alkenyl group Chemical group 0.000 claims 10
- 125000004122 cyclic group Chemical group 0.000 claims 10
- 125000004982 dihaloalkyl group Chemical group 0.000 claims 10
- 125000001188 haloalkyl group Chemical group 0.000 claims 10
- 125000004385 trihaloalkyl group Chemical group 0.000 claims 10
- 238000004519 manufacturing process Methods 0.000 claims 9
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 8
- 229910052799 carbon Inorganic materials 0.000 claims 8
- 125000000623 heterocyclic group Chemical group 0.000 claims 8
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 8
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims 4
- 206010013774 Dry eye Diseases 0.000 claims 4
- -1 polymorph Substances 0.000 claims 4
- 239000003098 androgen Substances 0.000 claims 3
- 239000003085 diluting agent Substances 0.000 claims 3
- 230000021595 spermatogenesis Effects 0.000 claims 3
- 101100149678 Caenorhabditis elegans snr-3 gene Proteins 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 102000001307 androgen receptors Human genes 0.000 claims 2
- 108010080146 androgen receptors Proteins 0.000 claims 2
- 230000006907 apoptotic process Effects 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 claims 2
- 229940124011 Androgen receptor agonist Drugs 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 230000003054 hormonal effect Effects 0.000 claims 1
- 238000002657 hormone replacement therapy Methods 0.000 claims 1
- 238000001794 hormone therapy Methods 0.000 claims 1
- 239000002583 male contraceptive agent Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- DWNQNCMBAMGKDR-NMIAKEAWSA-N C[C@H](C(CO)Oc(cc1)ccc1F)C(CCC1NCC1C(C=C1C(F)(F)F)=CCC1F)=O Chemical compound C[C@H](C(CO)Oc(cc1)ccc1F)C(CCC1NCC1C(C=C1C(F)(F)F)=CCC1F)=O DWNQNCMBAMGKDR-NMIAKEAWSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/270,732 | 2002-10-16 | ||
| US10/270,732 US6998500B2 (en) | 2000-08-24 | 2002-10-16 | Selective androgen receptor modulators and methods of use thereof |
| US10/371,213 | 2003-02-24 | ||
| US10/371,213 US7026500B2 (en) | 2000-08-24 | 2003-02-24 | Halogenated selective androgen receptor modulators and methods of use thereof |
| PCT/US2003/032507 WO2004035736A2 (en) | 2002-10-16 | 2003-10-14 | Halogenated selective androgen receptor modulators and methods of use thereof |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006060868A Division JP2006199704A (ja) | 2002-10-16 | 2006-03-07 | 選択的アンドロゲン受容体調節剤及びその使用方法 |
| JP2007121464A Division JP4694529B2 (ja) | 2002-10-16 | 2007-05-02 | 選択的アンドロゲン受容体調節剤及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006514098A JP2006514098A (ja) | 2006-04-27 |
| JP2006514098A5 true JP2006514098A5 (https=) | 2006-08-17 |
| JP4764719B2 JP4764719B2 (ja) | 2011-09-07 |
Family
ID=32109809
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005501406A Expired - Fee Related JP4764719B2 (ja) | 2002-10-16 | 2003-10-14 | ハロゲン化選択的アンドロゲン受容体調節剤及びその使用方法 |
| JP2006060868A Pending JP2006199704A (ja) | 2002-10-16 | 2006-03-07 | 選択的アンドロゲン受容体調節剤及びその使用方法 |
| JP2007121464A Expired - Fee Related JP4694529B2 (ja) | 2002-10-16 | 2007-05-02 | 選択的アンドロゲン受容体調節剤及びその使用方法 |
| JP2010282886A Pending JP2011052027A (ja) | 2002-10-16 | 2010-12-20 | 選択的アンドロゲン受容体調節剤及びその使用方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006060868A Pending JP2006199704A (ja) | 2002-10-16 | 2006-03-07 | 選択的アンドロゲン受容体調節剤及びその使用方法 |
| JP2007121464A Expired - Fee Related JP4694529B2 (ja) | 2002-10-16 | 2007-05-02 | 選択的アンドロゲン受容体調節剤及びその使用方法 |
| JP2010282886A Pending JP2011052027A (ja) | 2002-10-16 | 2010-12-20 | 選択的アンドロゲン受容体調節剤及びその使用方法 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7026500B2 (https=) |
| EP (3) | EP1558565B1 (https=) |
| JP (4) | JP4764719B2 (https=) |
| KR (3) | KR101069612B1 (https=) |
| CN (3) | CN101062023A (https=) |
| AT (1) | ATE430125T1 (https=) |
| AU (1) | AU2003287074B2 (https=) |
| BR (1) | BR0314891A (https=) |
| CA (3) | CA2538095C (https=) |
| CY (1) | CY1109858T1 (https=) |
| DE (1) | DE60327456D1 (https=) |
| DK (1) | DK1558565T3 (https=) |
| EA (2) | EA011744B1 (https=) |
| ES (1) | ES2324606T3 (https=) |
| GE (2) | GEP20094820B (https=) |
| HR (2) | HRP20070457A2 (https=) |
| IL (2) | IL182880A0 (https=) |
| MX (1) | MXPA05004076A (https=) |
| PT (1) | PT1558565E (https=) |
| SI (1) | SI1558565T1 (https=) |
| TW (1) | TWI332955B (https=) |
| WO (1) | WO2004035736A2 (https=) |
Families Citing this family (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7759520B2 (en) * | 1996-11-27 | 2010-07-20 | University Of Tennessee Research Foundation | Synthesis of selective androgen receptor modulators |
| US20040260108A1 (en) * | 2001-06-25 | 2004-12-23 | Dalton James T. | Metabolites of selective androgen receptor modulators and methods of use thereof |
| US20030232792A1 (en) * | 2000-08-24 | 2003-12-18 | Dalton James T. | Selective androgen receptor modulators and methods of use thereof |
| US8445534B2 (en) * | 2000-08-24 | 2013-05-21 | University Of Tennessee Research Foundation | Treating androgen decline in aging male (ADAM)-associated conditions with SARMs |
| US7855229B2 (en) * | 2000-08-24 | 2010-12-21 | University Of Tennessee Research Foundation | Treating wasting disorders with selective androgen receptor modulators |
| US7622503B2 (en) | 2000-08-24 | 2009-11-24 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and methods of use thereof |
| US7919647B2 (en) | 2000-08-24 | 2011-04-05 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and methods of use thereof |
| US7645898B2 (en) * | 2000-08-24 | 2010-01-12 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and method of use thereof |
| US7253210B2 (en) * | 2002-10-15 | 2007-08-07 | University Of Tennessee Research Foundation | Methylene-bridged selective androgen receptor modulators and methods of use thereof |
| US7547728B2 (en) * | 2001-12-06 | 2009-06-16 | University Of Tennessee Research Foundation | Treating muscle wasting with selective androgen receptor modulators |
| US20070173546A1 (en) * | 2000-08-24 | 2007-07-26 | Dalton James T | Selective androgen receptor modulators and method of use thereof |
| US20070161608A1 (en) * | 2001-12-06 | 2007-07-12 | Dalton James T | Selective androgen receptor modulators for treating muscle wasting |
| US8853266B2 (en) * | 2001-12-06 | 2014-10-07 | University Of Tennessee Research Foundation | Selective androgen receptor modulators for treating diabetes |
| US7772433B2 (en) * | 2002-02-28 | 2010-08-10 | University Of Tennessee Research Foundation | SARMS and method of use thereof |
| US20040197928A1 (en) * | 2002-10-15 | 2004-10-07 | Dalton James T. | Method for detecting selective androgen receptor modulators |
| US20060276539A1 (en) * | 2002-10-16 | 2006-12-07 | Dalton James T | Treating Androgen Decline in Aging Male (ADAM)- associated conditions with SARMS |
| WO2004035739A2 (en) * | 2002-10-16 | 2004-04-29 | Gtx, Inc. | Treating androgen decline in aging male (adam)-associated conditions with sarms |
| US8309603B2 (en) | 2004-06-07 | 2012-11-13 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| EP2457892A1 (en) * | 2003-01-13 | 2012-05-30 | University of Tennessee Research Foundation | Large-scale synthesis of selective androgen receptor modulators |
| JP2006516286A (ja) * | 2003-01-22 | 2006-06-29 | ジーティーエックス・インコーポレイテッド | Ｓａｒｍによる女性のアンドロゲン減少に関連する病気の治療 |
| FI20030958A0 (fi) * | 2003-06-27 | 2003-06-27 | Orion Corp | Uusia yhdisteitä |
| CA2535953C (en) * | 2003-10-14 | 2012-07-03 | Gtx, Inc. | Treating bone-related disorders with selective androgen receptor modulators |
| CA2522874A1 (en) * | 2003-12-16 | 2005-07-07 | Gtx, Inc. | Prodrugs of selective androgen receptor modulators and methods of use thereof |
| ATE552235T1 (de) * | 2004-06-07 | 2012-04-15 | Univ Tennessee Res Foundation | Selektive androgen-rezeptor-modulator und anwendungsverfahren dafür |
| US9884038B2 (en) | 2004-06-07 | 2018-02-06 | University Of Tennessee Research Foundation | Selective androgen receptor modulator and methods of use thereof |
| US20110237664A1 (en) * | 2004-06-07 | 2011-09-29 | Dalton James T | Selective androgen receptor modulators for treating diabetes |
| US9889110B2 (en) | 2004-06-07 | 2018-02-13 | University Of Tennessee Research Foundation | Selective androgen receptor modulator for treating hormone-related conditions |
| US9492400B2 (en) | 2004-11-04 | 2016-11-15 | Massachusetts Institute Of Technology | Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals |
| JP2009506119A (ja) * | 2005-08-31 | 2009-02-12 | ユニバーシティ オブ テネシー リサーチ ファウンデーション | 選択的アンドロゲン受容体モジュレーターを用いる腎疾患、熱傷、創傷および脊髄損傷の処置 |
| US9267937B2 (en) * | 2005-12-15 | 2016-02-23 | Massachusetts Institute Of Technology | System for screening particles |
| ES2776100T3 (es) | 2006-03-31 | 2020-07-29 | Massachusetts Inst Technology | Sistema para el suministro dirigido de agentes terapéuticos |
| US8367113B2 (en) | 2006-05-15 | 2013-02-05 | Massachusetts Institute Of Technology | Polymers for functional particles |
| US20110052697A1 (en) * | 2006-05-17 | 2011-03-03 | Gwangju Institute Of Science & Technology | Aptamer-Directed Drug Delivery |
| US8288366B2 (en) | 2006-06-20 | 2012-10-16 | Chochinov Ronald H | Formulation for hair growth |
| WO2007150030A2 (en) | 2006-06-23 | 2007-12-27 | Massachusetts Institute Of Technology | Microfluidic synthesis of organic nanoparticles |
| PT2038252T (pt) * | 2006-07-12 | 2016-12-16 | Univ Tennessee Res Found | Acilanilidos substituidos e métodos de utilização dos mesmos |
| US9730908B2 (en) | 2006-08-24 | 2017-08-15 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| CN101528214B (zh) * | 2006-08-24 | 2013-06-05 | 田纳西大学研究基金会 | 取代的n-酰基苯胺及其使用方法 |
| US10010521B2 (en) | 2006-08-24 | 2018-07-03 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| US9844528B2 (en) | 2006-08-24 | 2017-12-19 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| WO2008147456A2 (en) * | 2006-11-20 | 2008-12-04 | Massachusetts Institute Of Technology | Drug delivery systems using fc fragments |
| US9217129B2 (en) * | 2007-02-09 | 2015-12-22 | Massachusetts Institute Of Technology | Oscillating cell culture bioreactor |
| EP2136788B1 (en) | 2007-03-30 | 2011-10-26 | Bind Biosciences, Inc. | Cancer cell targeting using nanoparticles |
| WO2008124634A1 (en) | 2007-04-04 | 2008-10-16 | Massachusetts Institute Of Technology | Polymer-encapsulated reverse micelles |
| WO2008124632A1 (en) | 2007-04-04 | 2008-10-16 | Massachusetts Institute Of Technology | Amphiphilic compound assisted nanoparticles for targeted delivery |
| PL2176220T3 (pl) | 2007-08-07 | 2013-08-30 | Takeda Pharmaceuticals Co | Pochodne pirolidyn-2-onu jako modulatory receptora androgenowego |
| HRP20180500T1 (hr) * | 2007-09-11 | 2018-06-01 | Gtx, Inc. | Kristalni polimorf selektivnih modulatora androgena (r) ili (s)-n-(4-cijano-3-(trifluorometil)fenil)-3-(4-cijanofenoksi)-2-hidroksi-2-metilpropanamida |
| US7968603B2 (en) | 2007-09-11 | 2011-06-28 | University Of Tennessee Research Foundation | Solid forms of selective androgen receptor modulators |
| EP2630966B1 (en) | 2007-10-12 | 2017-04-19 | Massachusetts Institute of Technology | Vaccine nanotechnology |
| KR101595238B1 (ko) | 2007-12-21 | 2016-02-18 | 리간드 파마슈티칼스 인코포레이티드 | 선택적 안드로겐 수용체 조절제(ｓａｒｍ) 및 이의 용도 |
| US8506944B2 (en) * | 2008-05-07 | 2013-08-13 | The Regents Of The University Of California | Replenishment and enrichment of ocular surface lubrication |
| HUE024146T2 (en) * | 2008-05-07 | 2016-02-29 | Univ California | Medical filling and enrichment of eye surface lubrication |
| US8591905B2 (en) * | 2008-10-12 | 2013-11-26 | The Brigham And Women's Hospital, Inc. | Nicotine immunonanotherapeutics |
| US8343497B2 (en) | 2008-10-12 | 2013-01-01 | The Brigham And Women's Hospital, Inc. | Targeting of antigen presenting cells with immunonanotherapeutics |
| US8343498B2 (en) | 2008-10-12 | 2013-01-01 | Massachusetts Institute Of Technology | Adjuvant incorporation in immunonanotherapeutics |
| US8277812B2 (en) * | 2008-10-12 | 2012-10-02 | Massachusetts Institute Of Technology | Immunonanotherapeutics that provide IgG humoral response without T-cell antigen |
| KR20120022984A (ko) * | 2009-04-21 | 2012-03-12 | 셀렉타 바이오사이언시즈, 인크. | Ｔｈ１ 편향 반응을 제공하는 면역나노치료법 |
| CN103002737A (zh) * | 2010-01-11 | 2013-03-27 | Gtx公司 | 治疗睑板腺功能障碍的方法 |
| US8395552B2 (en) | 2010-11-23 | 2013-03-12 | Metamagnetics, Inc. | Antenna module having reduced size, high gain, and increased power efficiency |
| PT2872482T (pt) | 2012-07-13 | 2020-09-22 | Oncternal Therapeutics Inc | Método de tratamento de cancro de mama com modulador seletivo do recetor de andrógeno (sarm) |
| US10987334B2 (en) | 2012-07-13 | 2021-04-27 | University Of Tennessee Research Foundation | Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs) |
| US10258596B2 (en) | 2012-07-13 | 2019-04-16 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
| US10314807B2 (en) | 2012-07-13 | 2019-06-11 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
| US9969683B2 (en) | 2012-07-13 | 2018-05-15 | Gtx, Inc. | Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS) |
| US9744149B2 (en) | 2012-07-13 | 2017-08-29 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
| US9622992B2 (en) | 2012-07-13 | 2017-04-18 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
| RU2483742C1 (ru) * | 2012-07-18 | 2013-06-10 | Татьяна Владимировна Буткова | Способ лечения расстройств эрекции и расстройств полового влечения |
| NZ720499A (en) * | 2013-12-23 | 2020-04-24 | Bcn Peptides Sa | Bicalutamide analogs or (s)-bicalutamide as exocytosis activating compounds for use in the treatment of a lysosomal storage disorder or glycogenosis |
| EP3094323A4 (en) | 2014-01-17 | 2017-10-11 | Ligand Pharmaceuticals Incorporated | Methods and compositions for modulating hormone levels |
| RU2577225C1 (ru) * | 2015-03-27 | 2016-03-10 | Общество С Ограниченной Ответственностью "Парафарм" | Препарат и способ для лечения дефицита андрогенов у женщин, содержащий энтомологические протеины |
| RU2620020C2 (ru) * | 2015-10-06 | 2017-05-22 | Рустем Фрунзевич Байкеев | Способ идентификации сексуального статуса женщины с сексуальным либидо |
| JP2021523151A (ja) | 2018-05-11 | 2021-09-02 | ホスホレックス、インコーポレイテッド | 負の表面電荷を有するマイクロ粒子及びナノ粒子 |
| WO2019222272A1 (en) | 2018-05-14 | 2019-11-21 | Nuvation Bio Inc. | Anti-cancer nuclear hormone receptor-targeting compounds |
| AU2020257397B2 (en) | 2019-04-19 | 2026-02-26 | Ligand Pharmaceuticals Inc. | Crystalline forms and methods of producing crystalline forms of a compound |
| CN113811333B (zh) | 2019-05-14 | 2024-03-12 | 诺维逊生物股份有限公司 | 靶向抗癌核激素受体的化合物 |
| WO2021097046A1 (en) | 2019-11-13 | 2021-05-20 | Nuvation Bio Inc. | Anti-cancer nuclear hormone receptor-targeting compounds |
| JP2023544201A (ja) | 2020-10-08 | 2023-10-20 | ターグイミューン セラピューティクス アクチエンゲゼルシャフト | がんを処置するための免疫療法 |
| KR20230160299A (ko) | 2021-03-23 | 2023-11-23 | 누베이션 바이오 인크. | 항암 핵 호르몬 수용체 표적화 화합물 |
| US12006314B2 (en) | 2021-05-03 | 2024-06-11 | Nuvation Bio Inc. | Anti-cancer nuclear hormone receptor-targeting compounds |
| CA3237153A1 (en) | 2021-11-05 | 2023-05-11 | Targimmune Therapeutics Ag | Targeted linear conjugates comprising polyethyleneimine and polyethylene glycol and polyplexes comprising the same |
| KR20250105420A (ko) | 2022-11-07 | 2025-07-08 | 타르그이뮨 테라퓨틱스 아게 | 핵산 및 폴리에틸렌이민 및 폴리에틸렌 글리콜을 포함하는 표적화된 컨쥬게이트의 다중복합체 |
| KR20250106292A (ko) | 2022-11-07 | 2025-07-09 | 타르그이뮨 테라퓨틱스 아게 | 폴리에틸렌이민 및 폴리에틸렌 글리콜을 포함하는 psma 표적화 선형 컨쥬게이트 및 이들을 포함하는 다중복합체 |
| EP4615511A1 (en) | 2022-11-07 | 2025-09-17 | TargImmune Therapeutics AG | Targeted linear conjugates comprising polyethyleneimine and polyethylene glycol and polyplexes comprising the same |
| WO2025238236A1 (en) | 2024-05-16 | 2025-11-20 | Targimmune Therapeutics Ag | Polyplexes of nucleic acids and targeted conjugates comprising polyethyleneimine and polyethylene glycol |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1360001A (en) | 1971-06-16 | 1974-07-17 | Scherico Ltd | Pharmaceutical compositions comprising substituted anilides |
| US3875229A (en) | 1972-11-24 | 1975-04-01 | Schering Corp | Substituted carboxanilides |
| JPS6044294B2 (ja) | 1976-04-15 | 1985-10-02 | 帝国臓器製薬株式会社 | アニリド誘導体 |
| US4139638A (en) | 1976-09-23 | 1979-02-13 | Schering Corporation | Methods for the treatment of hirsutism |
| EP0002309B1 (en) | 1977-10-12 | 1982-12-01 | Imperial Chemical Industries Plc | Acylanilides, process for their manufacture and pharmaceutical and veterinary compositions containing them |
| US4191775A (en) | 1977-12-15 | 1980-03-04 | Imperial Chemical Industries Limited | Amide derivatives |
| NZ197008A (en) | 1980-05-22 | 1984-10-19 | Ici Ltd | Acylanilide derivatives and pharmaceutical compositions |
| JPS57171904A (en) | 1981-04-15 | 1982-10-22 | Mitsubishi Petrochem Co Ltd | Tri- or tetra-substituted phenoxycarboxylic acid anilide type herbicide |
| EP0100172B1 (en) | 1982-07-23 | 1987-08-12 | Imperial Chemical Industries Plc | Amide derivatives |
| GB8617653D0 (en) | 1986-07-18 | 1986-08-28 | Ici Plc | Amide derivatives |
| GB8617652D0 (en) | 1986-07-18 | 1986-08-28 | Ici Plc | Acylanilide derivatives |
| US5162504A (en) | 1988-06-03 | 1992-11-10 | Cytogen Corporation | Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients |
| DE9217131U1 (de) * | 1992-12-08 | 1993-03-11 | Chr. Berghöfer GmbH & Co. KG, 3500 Kassel | Armatur für einen Schlauch oder ein flexibles Rohr mit einer profilierten Außenfläche |
| CA2181358A1 (en) | 1994-01-21 | 1995-07-27 | Nancy M. Gray | Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex |
| US5609849A (en) | 1994-03-11 | 1997-03-11 | The Trustees Of The University Of Pennsylvania | Serotonin (5-HT1A) receptor ligands and imaging agents |
| US5656651A (en) | 1995-06-16 | 1997-08-12 | Biophysica Inc. | Androgenic directed compositions |
| WO1998005962A1 (en) | 1996-08-02 | 1998-02-12 | Panvera Corporation | A method for quantitating competitive binding of molecules to proteins utilizing fluorescence polarization |
| US6071957A (en) | 1996-11-27 | 2000-06-06 | The University Of Tennessee Research Corporation | Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer |
| US6160011A (en) | 1997-05-30 | 2000-12-12 | The University Of Tennessee Research Corporation | Non-steroidal agonist compounds and their use in male hormone therapy |
| WO1998055153A1 (en) | 1997-06-04 | 1998-12-10 | The University Of Tennessee Research Corporation | Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging |
| AU775928B2 (en) | 1999-10-14 | 2004-08-19 | Bristol-Myers Squibb Company | Crystallographic structure of the androgen receptor ligand binding domain |
| PL354620A1 (en) | 1999-10-19 | 2004-02-09 | Nobex Corporation | Methods of asymmetrically synthesizing enantiomers of casodex, its derivatives and intermediates thereof |
| CN1413188A (zh) | 1999-10-27 | 2003-04-23 | 诺贝克斯公司 | 基本纯的比卡鲁胺合成中中间体的拆分 |
| EP1118811A3 (de) * | 2000-01-19 | 2003-05-21 | Witzenmann GmbH | Flexibles Leitungselement mit einer an mindestens einem Ende angebrachten Anschlussvorrichtung |
| BR0111298A (pt) | 2000-06-28 | 2005-05-10 | Bristol Myers Squibb Co | Moduladores seletivos dos receptores de andrógenos e métodos para identificação, projeto e uso dos mesmos |
| EP1401801B1 (en) | 2000-08-24 | 2006-11-02 | The University Of Tennessee Research Corporation | Selective androgen receptor modulators and methods of use thereof |
| IL154425A0 (en) | 2000-08-24 | 2003-09-17 | Univ Tennessee Res H Corp | Selective androgen receptor modulators and methods of use thereof |
| US7547728B2 (en) * | 2001-12-06 | 2009-06-16 | University Of Tennessee Research Foundation | Treating muscle wasting with selective androgen receptor modulators |
| US6645974B2 (en) | 2001-07-31 | 2003-11-11 | Merck & Co., Inc. | Androgen receptor modulators and methods for use thereof |
| PT1480634E (pt) * | 2002-02-07 | 2011-10-12 | Univ Tennessee Res Foundation | Moduladores selectivos do receptor do androgénio (sarms) para o tratamento da hiperplasia benigna da próstata |
| TW200613306A (en) * | 2004-07-20 | 2006-05-01 | Osi Pharm Inc | Imidazotriazines as protein kinase inhibitors |
-
2003
- 2003-02-24 US US10/371,213 patent/US7026500B2/en not_active Expired - Fee Related
- 2003-10-14 PT PT03777595T patent/PT1558565E/pt unknown
- 2003-10-14 KR KR1020077010374A patent/KR101069612B1/ko not_active Expired - Fee Related
- 2003-10-14 HR HR20070457A patent/HRP20070457A2/xx not_active Application Discontinuation
- 2003-10-14 AU AU2003287074A patent/AU2003287074B2/en not_active Ceased
- 2003-10-14 AT AT03777595T patent/ATE430125T1/de active
- 2003-10-14 EA EA200500648A patent/EA011744B1/ru not_active IP Right Cessation
- 2003-10-14 EP EP03777595A patent/EP1558565B1/en not_active Expired - Lifetime
- 2003-10-14 EA EA200700854A patent/EA014932B1/ru not_active IP Right Cessation
- 2003-10-14 CA CA002538095A patent/CA2538095C/en not_active Expired - Fee Related
- 2003-10-14 GE GEAP200310055A patent/GEP20094820B/en unknown
- 2003-10-14 CA CA002588083A patent/CA2588083A1/en not_active Abandoned
- 2003-10-14 GE GEAP20038798A patent/GEP20084434B/en unknown
- 2003-10-14 HR HR20050334A patent/HRP20050334A2/xx not_active Application Discontinuation
- 2003-10-14 ES ES03777595T patent/ES2324606T3/es not_active Expired - Lifetime
- 2003-10-14 BR BR0314891-2A patent/BR0314891A/pt not_active IP Right Cessation
- 2003-10-14 MX MXPA05004076A patent/MXPA05004076A/es active IP Right Grant
- 2003-10-14 SI SI200331644T patent/SI1558565T1/sl unknown
- 2003-10-14 DK DK03777595T patent/DK1558565T3/da active
- 2003-10-14 DE DE60327456T patent/DE60327456D1/de not_active Expired - Lifetime
- 2003-10-14 CN CNA2007101041899A patent/CN101062023A/zh active Pending
- 2003-10-14 KR KR1020057006606A patent/KR101068779B1/ko not_active Expired - Fee Related
- 2003-10-14 CN CNA2007100842211A patent/CN100999481A/zh active Pending
- 2003-10-14 JP JP2005501406A patent/JP4764719B2/ja not_active Expired - Fee Related
- 2003-10-14 EP EP10075692A patent/EP2305636A1/en not_active Withdrawn
- 2003-10-14 KR KR1020107029192A patent/KR101107031B1/ko not_active Expired - Fee Related
- 2003-10-14 EP EP06026706A patent/EP1764357A1/en not_active Withdrawn
- 2003-10-14 CA CA002502355A patent/CA2502355A1/en not_active Abandoned
- 2003-10-14 WO PCT/US2003/032507 patent/WO2004035736A2/en not_active Ceased
- 2003-10-14 CN CN200380106307XA patent/CN1726185B/zh not_active Expired - Fee Related
- 2003-10-16 TW TW092128713A patent/TWI332955B/zh not_active IP Right Cessation
-
2006
- 2006-03-07 JP JP2006060868A patent/JP2006199704A/ja active Pending
-
2007
- 2007-04-30 IL IL182880A patent/IL182880A0/en unknown
- 2007-05-02 JP JP2007121464A patent/JP4694529B2/ja not_active Expired - Fee Related
-
2008
- 2008-04-17 IL IL190931A patent/IL190931A0/en unknown
-
2009
- 2009-07-23 CY CY20091100794T patent/CY1109858T1/el unknown
-
2010
- 2010-12-20 JP JP2010282886A patent/JP2011052027A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006514098A5 (https=) | ||
| JP2006518328A5 (https=) | ||
| JP2006506369A5 (https=) | ||
| JP2005526741A5 (https=) | ||
| JP2006511486A5 (https=) | ||
| JP6434482B2 (ja) | 置換アシルアニリドおよびそれらの使用方法 | |
| JP2009506119A5 (https=) | ||
| ES2784454T3 (es) | Aril éteres y usos de los mismos | |
| JP2019517487A5 (https=) | ||
| JP2007538094A5 (https=) | ||
| JP2011500621A5 (https=) | ||
| JP2010509356A5 (https=) | ||
| MY189118A (en) | Pyrazolo[1,5-a]pyrazin-4-yl derivatives | |
| JP2013532652A5 (https=) | ||
| CA2621189A1 (en) | Treating renal disease, burns, wounds and spinal cord injury with selective androgen receptor modulators | |
| JP2013545785A5 (https=) | ||
| RU2016137181A (ru) | Противофиброзные пиридиноны | |
| JP2015537020A5 (https=) | ||
| RU2006112428A (ru) | Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение | |
| JP2010512419A (ja) | 医薬組成物およびそれの使用方法 | |
| RU2013156361A (ru) | Новые соединения | |
| TW201333012A (zh) | 咪唑并吡咯啶酮化合物 | |
| JP2013056886A5 (https=) | ||
| JP2009513703A5 (https=) | ||
| JPWO2023099623A5 (https=) |